跳至主要内容
临床试验/NL-OMON30649
NL-OMON30649已完成3 期

A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone - TxMG trial

ational Institute of Health0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •Male and female MG patients aged 18 to 60 years inclusive (thymectomy is not regularly performed in non-thymomatous MG patients > 60 years of age).
  • •Onset of generalized MG within the last 3 years.
  • •Positive serum anti-acetylcholine receptor binding antibodies (AChR Ab <=/> 1.0 nmol/L).
  • •MGFA class II-IV at entry, using the MG Foundation of America (MGFA) classification, while receiving optimal anti-cholinesterase treatment with or without oral prednisone.

排除标准

  • •Ocular MG without generalized weakness (MGFA Class I) or minimal weakness that would not require the use of corticosteroids.
  • •Myasthenic weakness requiring intubation (MGFA class V) in the prior month.
  • •Immunosuppressive therapy other than corticosteroids in the preceding year.
  • •Medically unfit for thymectomy.
  • •Chest computertomogreaphy evidence for thymoma.
  • •Pregnancy or lactation; contraindications to the use of corticosteroids; unwillingness to practice effective contraception.
  • •A serious concurrent medical, neurological or psychiatric condition.
  • •Current daily dose of prednisone of more than 50 mg.
  • •Participation in another experimental clinical trial.
  • •History of alcohol or drug abuse.
  • •Unwillingness or inability to comply with the requirements of the protocol.

研究者

发起方
ational Institute of Health

相似试验

未知
3 期
K-103-PA Phase 3 studySoft tissue pain
JPRN-jRCT2080221217Kowa Co., Ltd.340
进行中(未招募)
不适用
Clinical trial to compare safety and efficacy of CGBIO stent and Biomatrix Flex stent in patients receiving drug-eluting stent after coronary angiographyDiseases of the circulatory system
KCT0003759CGBio118
进行中(未招募)
1 期
An examination of which type of medicine (rocuronium or remifentanil) is better concerning placement of a tube in trachea in elderly patients under going anesthesiaThe aim of this study is to determine the effect on intubating conditionsand laryngeal morbidity after either rocuronium 0.6 mg/kg or remifentanil 2 µg/kg in patients with age = 80 years.MedDRA version: 21.1Level: LLTClassification code 10002323Term: Anesthesia generalSystem Organ Class: 100000004865
EUCTR2019-004121-25-DKRigshospitalet74
进行中(未招募)
1 期
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non Radiographic Axial SpondyloarthritisAxial SpondyloarthritisMedDRA version: 17.0Level: LLTClassification code 10071400Term: Axial spondyloarthritisSystem Organ Class: 100000004859
EUCTR2012-000646-35-BEAbbVie Deutschland GmbH & Co. KG740
已完成
4 期
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non Radiographic Axial SpondyloarthritisAxial spine arthritisinflammation of the spine and joints1000381610023213
NL-OMON41245AbbVie B.V.54